Treatment of Pulmonary Tuberculosis

Initial Phase (First 2 Months)

The American Academy of Family Physicians recommends a 6-month regimen consisting of isoniazid, rifampin, pyrazinamide, and ethambutol daily for 2 months (intensive phase), followed by isoniazid and rifampin daily for 4 months (continuation phase) for newly diagnosed drug-sensitive pulmonary tuberculosis 1, 2
Four-drug therapy is essential during the intensive phase, with isoniazid, rifampin, pyrazinamide, and ethambutol administered together daily for 8 weeks 1, 2
The intensive phase rapidly kills tubercle bacilli and renders patients non-infectious within weeks, with rifampin dosed at 10 mg/kg daily 3
Pyrazinamide is dosed at 25 mg/kg daily during the intensive phase 3
Ethambutol is dosed at 15 mg/kg daily during the intensive phase 3

The American Academy of Family Physicians recommends isoniazid and rifampin daily for 4 additional months (total treatment duration: 6 months) for patients with non-cavitary disease who have negative sputum cultures at 2 months 1, 2, 4
An extended continuation phase (7 months total, for 9 months treatment) is required for cavitary pulmonary tuberculosis on initial chest radiograph with positive sputum culture at 2 months 1, 2

The Centers for Disease Control and Prevention recommends obtaining baseline testing before treatment, including medical history, physical examination, chest x-ray, tuberculin skin test, and at least three sputum specimens for acid-fast bacilli smear, culture, and drug susceptibility testing 5
HIV antibody testing and counseling are also recommended before treatment 5, 2
Baseline liver function tests are recommended if the patient has risk factors for hepatotoxicity 4
Monthly sputum cultures are recommended until two consecutive negatives are documented 6

The American Academy of Family Physicians recommends using the same 6-month regimen as HIV-negative patients for HIV-positive patients, with directly observed therapy and avoiding once-weekly isoniazid-rifapentine in the continuation phase 2
For pregnant women, the American Thoracic Society recommends initiating standard treatment whenever tuberculosis is suspected, using isoniazid, rifampin, pyrazinamide, and ethambutol safely, and avoiding streptomycin due to its ototoxicity to the fetus 2, 4
Breastfeeding is safe while on first-line antituberculosis medications, but counseling about reduced oral contraceptive effectiveness with rifampin is recommended 4

The World Health Organization recommends assuming drug resistance until proven otherwise, starting with at least 4-5 drugs that the patient has NOT received previously, including a fluoroquinolone if available, and obtaining drug susceptibility testing immediately for isoniazid, rifampin, pyrazinamide, and fluoroquinolones 6
Implementing directly observed therapy for all recurrent cases is recommended 6

The American Academy of Family Physicians recommends continuous treatment, particularly in the initial phase, and avoiding treatment interruptions whenever possible 2
Directly observed therapy (DOT) should be implemented for all intermittent regimens, HIV-positive patients, and recurrent cases, as it improves adherence and treatment success, particularly in high-risk populations 1, 5, 6